These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 39212374)

  • 1. Sex-related differences in severe native valvular heart disease: the ESC-EORP Valvular Heart Disease II survey.
    Mascherbauer J; Kammerlander A; Nitsche C; Bax J; Delgado V; Evangelista A; Laroche C; Maggioni AP; Magne J; Vahanian A; Iung B
    Eur Heart J; 2024 Oct; 45(37):3818-3833. PubMed ID: 39212374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tricuspid regurgitation: Frequency, clinical presentation, management and outcome among patients with severe left-sided valvular heart disease in Europe. Insights from the ESC-EORP Valvular Heart Disease II survey.
    Dreyfus J; Komar M; Attias D; De Bonis M; Ruschitzka F; Popescu BA; Laroche C; Tribouilloy C; Bogachev Prokophiev A; Mizariene V; Bax JJ; Maggioni AP; Messika-Zeitoun D; Vahanian A; Iung B;
    Eur J Heart Fail; 2024 Apr; 26(4):994-1003. PubMed ID: 38374610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary Presentation and Management of Valvular Heart Disease: The EURObservational Research Programme Valvular Heart Disease II Survey.
    Iung B; Delgado V; Rosenhek R; Price S; Prendergast B; Wendler O; De Bonis M; Tribouilloy C; Evangelista A; Bogachev-Prokophiev A; Apor A; Ince H; Laroche C; Popescu BA; Piérard L; Haude M; Hindricks G; Ruschitzka F; Windecker S; Bax JJ; Maggioni A; Vahanian A;
    Circulation; 2019 Oct; 140(14):1156-1169. PubMed ID: 31510787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics, management, and outcomes of patients with multiple native valvular heart disease: a substudy of the EURObservational Research Programme Valvular Heart Disease II Survey.
    Tribouilloy C; Bohbot Y; Kubala M; Ruschitzka F; Popescu B; Wendler O; Laroche C; Bartha E; Ince H; Simkova I; Vahanian A; Iung B
    Eur Heart J; 2022 Aug; 43(29):2756-2766. PubMed ID: 35511056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution, Characteristics, and Management of Older Patients With Valvular Heart Disease in China: China-DVD Study.
    Xu H; Liu Q; Cao K; Ye Y; Zhang B; Li Z; Hao J; Qi X; Zhao Q; Liu S; Gao R; Wu Y;
    JACC Asia; 2022 Jun; 2(3):354-365. PubMed ID: 36338396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical characteristics of patients with moderate or severe valvular heart disease].
    Gao H; Lei YZ; Huang HY; Xu X; Zhang C; Zhu JF; Li LH; Zeng M; Chen SH; He JL; Chen YX; Zhang ZH
    Zhonghua Xin Xue Guan Bing Za Zhi; 2024 Oct; 52(10):1200-1206. PubMed ID: 39428370
    [No Abstract]   [Full Text] [Related]  

  • 7. Epidemiology of valvular heart disease in a Swedish nationwide hospital-based register study.
    Andell P; Li X; Martinsson A; Andersson C; Stagmo M; Zöller B; Sundquist K; Smith JG
    Heart; 2017 Nov; 103(21):1696-1703. PubMed ID: 28432156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of long-term exposure to traffic-related air pollution with risk of valvular heart disease based on a cross-sectional study.
    Pang Y; Liu S; Yan L; Wang Q; Li L; Chu C; Ning J; Zhang B; Wang X; Ma S; Su D; Zhang R; Niu Y
    Ecotoxicol Environ Saf; 2021 Feb; 209():111753. PubMed ID: 33348255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease.
    Iung B; Baron G; Butchart EG; Delahaye F; Gohlke-Bärwolf C; Levang OW; Tornos P; Vanoverschelde JL; Vermeer F; Boersma E; Ravaud P; Vahanian A
    Eur Heart J; 2003 Jul; 24(13):1231-43. PubMed ID: 12831818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein(a) is a risk factor for aortic and mitral valvular stenosis in peripheral arterial disease.
    Hojo Y; Kumakura H; Kanai H; Iwasaki T; Ichikawa S; Kurabayashi M
    Eur Heart J Cardiovasc Imaging; 2016 May; 17(5):492-7. PubMed ID: 26758409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive management of significant tricuspid regurgitation in clinical practice.
    Moral S; Abulí M; Méndez I; González-Gómez A; García-Quintana A; Menduiña I; Payá R; Esteban E; Sánchez PL; Díaz E; de la Morena G; Calvo-Iglesias F; Gallego P; Ballesteros E; Brugada R; Evangelista A
    Int J Cardiol; 2023 Mar; 375():66-73. PubMed ID: 36642332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, Characteristics, and Outcomes of Valvular Heart Disease in Patients With Atrial Fibrillation: Insights From the ORBIT-AF (Outcomes Registry for Better Informed Treatment for Atrial Fibrillation).
    Thomas KL; Jackson LR; Shrader P; Ansell J; Fonarow GC; Gersh B; Kowey PR; Mahaffey KW; Singer DE; Thomas L; Piccini JP; Peterson ED
    J Am Heart Assoc; 2017 Dec; 6(12):. PubMed ID: 29273635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequency and Clinical Associating Factors of Valvular Heart Disease in Asymptomatic Korean Adults.
    Kim MS; Cho SJ; Park SJ; Cho SW; Choi SH; Kim HS; Carriere K; Kim EK; Chang SA; Lee SC; Park SW
    Sci Rep; 2019 Nov; 9(1):16741. PubMed ID: 31727975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between valvular structure and biochemical indices of non-valvular atrial fibrillation and senile degenerative valvular heart disease.
    Chen JQ; Zeng X; Li KC; Huang JL; Guo BL; Zhou X
    J Thorac Dis; 2023 Feb; 15(2):611-619. PubMed ID: 36910075
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic implications of valvular heart disease in patients with non-valvular atrial fibrillation.
    Samaras A; Vrana E; Kartas A; Moysidis DV; Papazoglou AS; Doundoulakis I; Fotos G; Rampidis G; Tsalikakis DG; Efthimiadis G; Karvounis H; Tzikas A; Giannakoulas G
    BMC Cardiovasc Disord; 2021 Sep; 21(1):453. PubMed ID: 34536990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left-sided valvular heart disease and survival in out-of-hospital cardiac arrest: a nationwide registry-based study.
    Dejby E; Bhatt DL; Skoglund K; Rawshani A; Omerovic E; Redfors B; Myredal A; Petursson P; Angerås O; Gustafsson A; Isaksén D; Herlitz J; Rawshani A
    Sci Rep; 2023 Aug; 13(1):12662. PubMed ID: 37542095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis Global Group in Chronic Heart Failure score for the prediction of mortality in valvular heart disease.
    Lv J; Xu H; Ye Y; Li Z; Wang W; Zhang B; Zhao Q; Zhang H; Zhao Z; Liu Q; Wang B; Duan Z; Yu Z; Guo S; Zhao Y; Gao R; Ge J; Wu Y;
    ESC Heart Fail; 2024 Feb; 11(1):349-365. PubMed ID: 38012105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex and Race Differences in the Pathophysiology, Diagnosis, Treatment, and Outcomes of Valvular Heart Diseases.
    Fleury MA; Clavel MA
    Can J Cardiol; 2021 Jul; 37(7):980-991. PubMed ID: 33581193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery disease is associated with valvular heart disease, but could it Be a predictive factor?
    Matta A; Moussallem N
    Indian Heart J; 2019; 71(3):284-287. PubMed ID: 31543203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends and Disparities in Valvular Heart Disease Mortality in the United States From 1999 to 2020.
    Tan MC; Yeo YH; San BJ; Suleiman A; Lee JZ; Chatterjee A; Sell-Dottin KA; Sweeney JP; Fortuin FD; Lee KS
    J Am Heart Assoc; 2024 Apr; 13(8):e030895. PubMed ID: 38587138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.